Comparison of the effectiveness of Tetracosectide with triamcinolone in rotator cuff tenosynovitis

A comparative study of an intramuscular Tetracosectide single dose effect with triamcinolone subacromial injection effect in improving pain and shoulder joint function in rotator cuff tendinitis.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240110060673N1

Enrollment

Registered

2024-02-14

Start date

2024-03-20

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tendonitis. Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

Interventions

Intervention 1: The first intervention group: group of single-dose subacromial injection of 40 mg of triamcinolone acetonide (Cortiran 40 mg/ml, Iran Hormone, Tehran, Iran), injected by an orthopedic

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of rotator cuff tendonitis, age over 18 years, willingness to participate in the study, absence of underlying disease

Exclusion criteria

Exclusion criteria: Fibromyalgia, drug use and lack of follow-up

Design outcomes

Primary

Measure	Time frame
Pain intensity score on visual analog scale. Timepoint: Measurement of pain intensity at the beginning of the study, one month after a single dose of tetracosactide or triamcinolone. Method of measurement: Use of a visual analog scale ruler.;Pain intensity score and shoulder joint function in constant Murley. Timepoint: Measurement of pain intensity and function of the shoulder joint at the beginning of the study and one month after the injection of a single dose of tetracosactide or triamcinolone. Method of measurement: Constant-Murley Questionnaire.	—

Measure

Time frame

Pain intensity score on visual analog scale. Timepoint: Measurement of pain intensity at the beginning of the study, one month after a single dose of tetracosactide or triamcinolone. Method of measurement: Use of a visual analog scale ruler.;Pain intensity score and shoulder joint function in constant Murley. Timepoint: Measurement of pain intensity and function of the shoulder joint at the beginning of the study and one month after the injection of a single dose of tetracosactide or triamcinolone. Method of measurement: Constant-Murley Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirpasha Mansour

Tehran University of Medical Sciences

dr.pasha.m@gmail.com+98 21 6119 2240

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026